IQVIA Holdings Inc. has announced a strategic collaboration with the Duke Clinical Research Institute (DCRI) to advance clinical research in obesity and related cardiometabolic conditions. This partnership combines IQVIA's global clinical research expertise and operational capabilities with DCRI's academic rigor and experience in executing complex, multi-center trials. The collaboration aims to accelerate clinical trial planning and delivery by expanding access to diverse patient populations across 56 countries and over 3,000 sites, leveraging advanced analytics and real-world data, and ensuring coordinated support for all stakeholders involved in the clinical trial process.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IQVIA Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260210139483) on February 10, 2026, and is solely responsible for the information contained therein.